Background
==========

The presence of an accessory spleen (AS) at autopsy is estimated to be about 10%, almost 20% of which are found in or attached to the tail of the pancreas \[[@B1],[@B2]\]. Epidermoid cysts (ECs) account for 10% of benign non-parasitic cysts of the spleen \[[@B3]\]. However, the presence of an EC in an AS is very rare, with 33 cases of ECs found in an intrapancreatic (IP) AS \[[@B4]-[@B36]\], and only one in an AS located in the greater omentum \[[@B3]\].

Herein, we report on a case of an epidermoid cyst in intrapancreatic accessory spleen (ECIPAS), and make a comprehensive review of the literature.

Case presentation
=================

A 63-year-old Caucasian woman was admitted to our hospital with a one-week history of nausea and vomiting after meals. Her medical history included surgery for a peptic ulcer at the age of 48 years. Physical examination was essentially unremarkable. Laboratory data showed normal values. Enhanced-contrast abdominal computed tomography (CT) revealed a mass lesion with solid and cystic components detected in the tail of the pancreas (Figure  [1](#F1){ref-type="fig"}). As concerns serum tumor markers, carbohydrate antigen (CA) 19-9 levels had increased to 222 U/ml (reference range 0 to 27 U/ml). Because a malignant tumor of the pancreas was suspected, the patient underwent a distal pancreatectomy and splenectomy.

![Enhanced computed tomography (CT) shows the presence of a cystic lesion in the tail of the pancreas.](1477-7819-12-92-1){#F1}

The cyst measured 12.6 cm at its greatest diameter (Figure  [2](#F2){ref-type="fig"}), and contained a brownish serous composition fluid. No hair or skin appendages were found. Biochemical analysis of the cystic fluid revealed a markedly high level of CA 19-9 (5,000 U/mL) and a moderate elevation of CEA (180.4 ng/ml). Microscopically, the cyst was lined with multilayered (two to five layers thick) flattened epithelium, reminiscent of squamous epithelium above a red pulp splenic parenchyma (Figure  [3](#F3){ref-type="fig"}a). Immunohistochemistry showed that the epithelial cells were positive for keratins AE1/AE3 (Figure  [3](#F3){ref-type="fig"}b), CA 19-9 (Figure  [3](#F3){ref-type="fig"}c) and pCEA (Figure  [3](#F3){ref-type="fig"}d) and negative for vimentin, calretinin and thrombomodulin. Basal epithelial cells where focally reactive with antibodies against D2-40 (Figure  [3](#F3){ref-type="fig"}e) and HBME-1 (Figure  [3](#F3){ref-type="fig"}f). The pathological diagnosis indicated a true epithelial cyst of IPAS.

![Gross appearance of the epidermoid cyst in intrapancreatic accessory spleen (ECIPAS), with 12.6 cm at its greatest diameter.](1477-7819-12-92-2){#F2}

![**Histopathological findings.** Microscopically, the lining epithelium in this area **(a)** consists of two to three layers thick squamous flattened epithelium above a red pulp splenic parenchyma (H&E, x20). Immunohistochemical characteristics of the lining epithelium: note positive staining for **(b)** keratins AE1/AE3, **(c)** CA 19-9, **(d)** pCEA, absence of reactivity for **(e)** vimentin, **(f)** calretinin, and **(g)** thrombomodulin, and focal positivity for **(h)** D2-40 and **(i)** HBME-1 (H&E, x20).](1477-7819-12-92-3){#F3}

Postoperatively, CA 19-9 serum decreased to normal levels after one and a half months. One year later, the patient remains in good health.

Discussion
==========

In 1980, Davidson *et al*. \[[@B4]\] reported the first case of ECIPAS; and since then 33 articles and 36 patients have been reported in the English language literature (Table  [1](#T1){ref-type="table"}), suggesting the rarity of the disease. However, the exact incidence of ECIPAS is difficult to determine as over 50% of the cases were incidentally detected \[[@B8],[@B9],[@B12],[@B14],[@B15],[@B18],[@B19],[@B22]-[@B24]\], \[[@B26],[@B27],[@B30],[@B32],[@B34]\]. The mean age of the patients was 46.1 years (range 12 to 70 years), with a female preponderance (58.3%) \[[@B6],[@B7],[@B10]-[@B13],[@B16],[@B17],[@B19]-[@B21],[@B24]-[@B26],[@B28]\], \[[@B31],[@B33],[@B34],[@B36]\]. It is noteworthy that the majority of patients were of Asian origin (28/36 patients, 77.7%), suggesting possibly the presence of a racial factor \[[@B26],[@B27]\].

###### 

List of all published cases of epidermoid cyst in intrapancreatic accessory spleen (ECIPAS) in the English language literature

  **Case**   **Author**                             **Sex**   **Age (years)**                     **Presentation**                      **Location**   **Size (cm)**   **Serum markers**   **Preoperative diagnosis**                      **Surgery**                     
  ---------- ------------------------------------- --------- ----------------- ------------------------------------------------------- -------------- --------------- ------------------- ---------------------------- --------------------------------------------------- -----------------------------------
  1          Davidson *et al*., 1980 \[[@B4]\]       Male           40                         Nausea, WL, chest pain                       Tail            5.5               NI                       NI                  Pseudocyst, cystadenoma, cystadenocarcinoma                   DP/SPL
  2          Hanada *et al*., 1981 \[[@B5]\]         Male           51                                   RLQ                                Tail             6                NI                       NI                                  Pseudocyst                                    DP/SPL
  3          Morodoshi *et al*., 1991 \[[@B6]\]     Female          32                           Left abdominal pain                        Tail             6              Normal                   Normal                              Pancreatic cyst                              Cyst removal
  4          Nakae *et al*., 1991 \[[@B7]\]         Female          37                             Epigastric pain                          Tail            6.5               NI                       NI                                Pancreatic cyst                          Spleen preserving DP
  5          Tang *et al*., 1994 \[[@B8]\]           Male           38                              Asymptomatic                            Tail            1.4               NI                       NI                                      \-                                        DP/SPL
  6          Furukawa *et al*., 1998 \[[@B9]\]       Male           45                              Asymptomatic                            Tail            2.0               NI                       NI                            Primary cystic neoplasm                               DP
  7          Higaki *et al*., 1998 \[[@B10]\]       Female          46                             Left back pain                           Tail            \-                NI                       \+                                Malignant tumor                                 DP/SPL
  8          Tateyama *et al*., 1998 \[[@B11]\]     Female          67          Abdominal fullness, intermittent upper abdominal pain       Tail            3.0               \+                       \+                                      \-                                        DP/SPL
  9          Sasou *et al*., 1999 \[[@B12]\]        Female          49                              Asymptomatic                            Tail            4.3               NI                       NI                         Cystic tumor of the pancreas                           DP/SPL
  10         Choi *et al*., 2000 \[[@B13]\]         Female          54                  Epigastric pain, nausea, vomiting, WL               Tail            15                NI                       NI                       Benign cyst of the pancreas or AS                        DP/SPL
  11         Tsutsumi *et al*., 2000 \[[@B14]\]      Male           51                              Asymptomatic                            Tail            51              Normal                   Normal                        Benign cyst of the pancreas                           DP/SPL
  12         Horibe *et al*., 2001 \[[@B15]\]        Male           48                              Asymptomatic                            Tail            2.0               \-                       \+                        MCN producing pancreatic tumor                          DP/SPL
  13         Sonomura *et al*., 2002 \[[@B16]\]     Female          45                             Epigastric pain                          Tail            3.5               \-                       \-               Cystadenocarcinoma or solid tumor of the pancreas                DP/SPL
  14         Fink *et al*., 2002 \[[@B17]\]         Female          12                                  Fever                               Tail            2.0               \-                       \-                            Infected abdominal cyst                          Cyst removal
  15         Yokomizo *et al.*, 2002 \[[@B18]\]      Male           38                              Asymptomatic                            Tail            3.0               \-                       ++                 Mucinous cystadenoma, adenocarcinoma, ECIPAS                   DP/SPL
  16         Kanazawa *et al*., 2004 \[[@B19]\]     Female          58                              Asymptomatic                            Tail            2.5               \-                       \+                                      MCN                                Spleen preserving DP
  17         Watanabe *et al*., 2004 \[[@B20]\]     Female          55                       Postprandial epigastralgia                     Tail             3              Normal                     ++                   Mucinous cystadenoma, cystadenocarcinoma                     DP/SPL
  18         Won *et al*., 2005 \[[@B21]\]           Male           32                              Asymptomatic                            Tail            7.5               NI                       \+                             Pancreatic pseudocyst                       Spleen preserving DP
             Won *et al*., 2005 \[[@B21]\]          Female          49                           LUQ abdominal pain                         Tail            2.0             Normal                   Normal                         Serous or MCN cystadenoma                        Laparoscopic DP
  19         Ru *et al*., 2007 \[[@B22]\]            Male           41                              Asymptomatic                            Tail            2.5               NI                       \-                         Cystic lesion of the pancreas                          DP/SPL
  20         Itano *et al*., 2008 \[[@B23]\]         Male           40                              Asymptomatic                            Tail            4.0             Normal                   Normal                                  ECIPAS                                      DP/SPL
  21         Servais *et al*., 2008 \[[@B24]\]      Female          52                              Asymptomatic                            Tail           10.0               \+                       \+                         Malignant pancreatic neoplasm                          DP/SPL
  22         Gleeson *et al*., 2008 \[[@B25]\]      Female          32                                RUQ pain                              Tail            1.5               \-                       \-                          Cystic pancreatic neoplasm                            DP/SPL
  23         Zhang *et al*., 2009 \[[@B26]\]        Female          26                              Asymptomatic                            Tail            2.5             Normal                   Normal                                Primary MCN                            Spleen preserving DP
  24         Reiss *et al*., 2009 \[[@B27]\]         Male           49                              Asymptomatic                            Tail            3.6               NI                       NI                                      MCN                                       DP/SPL
  25         Kadota *et al*., 2010 \[[@B28]\]       Female          57                              Asymptomatic                            Tail            2.6             Normal                   Normal                          Pancreatic cystic tumor                               DP
             Kadota *et al*., 2010 \[[@B28]\]       Female          70                              Asymptomatic                            Tail            6.0             Normal                   Normal                                    MCN                                       DP/SPL
             Kadota *et al*., 2010 \[[@B28]\]        Male           37                              Asymptomatic                            Tail            2.6             Normal                   Normal               Serous cystic tumor or lymphoepithelial cyst                     DP
  26         Itano *et al*., 2010 \[[@B29]\]         Male           67                           Epigastric pain, WL                        Tail            2.2               NI                       \+                                    ECIPAS                               Laparoscopic DP /SPL
  27         Horn *et al*., 2011 \[[@B30]\]          Male           62                        Abdominal pain left-sided                     Tail            4.8               NI                       NI                    Retroperitoneal left-sided cystic mass                   Cyst removal
  28         Iwasaki *et al*., 2011 \[[@B32]\]      Female          36                              Asymptomatic                            Tail            3.4               NI                       \+                                      MCN                                 Laparoscopic DP/SPL
  29         Yamanishi *et al*., 2011 \[[@B31]\]    Female          55                              Asymptomatic                            Tail            3.3                N                       \+                                      MCN                                         DP
  30         Urakami *et al*., 2011 \[[@B33]\]      Female          50                              Asymptomatic                            Tail            3.0               NI                       NI                     ECIPAS or other cystic tumor in IPAS          Laparoscopic spleen preserving DP
  31         Khashab *et al*., 2011 \[[@B34]\]      Female          49                       Nonspecific abdominal pain                     Tail            2.3               NI                       NI                                     PNET                          Laparoscopic spleen preserving DP
  32         Harris *et al*., 2012 \[[@B35]\]       Female          39                              Asymptomatic                            Tail            2.0               \+                       NI                            Malignant cystic tumor                        Laparoscopic DP/SPL
  33         Hong *et al*., 2013 \[[@B36]\]         Female          54                          Abdominal discomfort                        Tail            2.3               NI                       NI                                      NI                                 Spleen preserving DP
  34         Our patient                            Female          63                            Nausea, vomiting                          Tail           12.6             Normal                     \+                                                                                DP/SPL

WL: weight loss, NI: no information, DP: distal pancreatectomy, SPL: splenctomy, RLQ: Right lower quadrant, MCN: Mucinous neoplasm, LUQ: Left upper quadrant, PNET: Pancreatic neuroendocrine tumor.

The precise histogenesis of an ECIPAS is not well understood. In summarizing the results of the literature, three main theories have been proposed. The first is based on similar studies of the histogenesis of ECs in the normal spleen suggesting an invagination of capsular mesothelium with subsequent cystic formation and metaplastic changes \[[@B37],[@B38]\]. The second, based on the presence of keratokine profile of a splenic cyst advocated that ECs are of teratomatous derivation or from inclusion of fetal squamous epithelium \[[@B39]\]. The third, based on immunohistochemical findings, suggests that an ECIPAS may derive either from an aberrant embryonic inclusion of the pancreatic duct epithelium \[[@B6]\], or from a protrusion of a pancreatic duct into an IPAS \[[@B11]\]. The later is questionable as macroscopically, Yokomizo *et al*. \[[@B18]\] and Iwasaki *et al*. \[[@B31]\] by using retrograde pancreatography, and Urakami *et al*. \[[@B32]\] by using magnetic resonance cholangiopancreatography, found no relationship between the pancreatic duct and the ECIPAS.

The histological findings of an ECIPAS in most cases demonstrate a unilocular or multilocular cyst lined by stratified squamous epithelium, keratinizing or not, and surrounded by normal splenic tissue \[[@B4]-[@B17],[@B19]-[@B23],[@B26]-[@B29],[@B32]-[@B34]\]. No skin appendages have been identified \[[@B4]-[@B34]\]. Immunohistochemical examinations of lining epithelium demonstrate positivity for CA 19-9 \[[@B6],[@B10]-[@B12],[@B15],[@B18],[@B20],[@B22],[@B24],[@B27]\], \[[@B30]\] and CEA \[[@B10]-[@B12],[@B15],[@B22],[@B24],[@B29]\]. Our immunohistochemical findings were found to accord with those of the above mentioned studies, showing positivity for anti-CA 19-9 and anti-pCEA antibodies. According to Higaki *et al*. \[[@B10]\], the high levels of CA 19-9 and/or CEA in the serum and in the cystic fluid \[[@B11]\] are produced by the squamous epithelium lining and released into the circulation due to trauma or increased intracystic pressure. The fall in levels noted after surgery further supports this suggestion \[[@B10]\].

The clinical presentation is not characteristic. Symptoms include epigastric pain, abdominal pain/discomfort, nausea, vomiting, and weight loss. However, in the reviewed cases, twenty patients (58.3%) (Table  [1](#T1){ref-type="table"}) were asymptomatic and were identified during radiological examinations for other reasons.

At present, U/S, CT-scan, and MRI are the main imaging tools to detect the lesion. The diameter of the cyst in the reported cases varied from 1.4 to 15 cm (mean 3.89 cm, 2.66 SD). On MRI, the cystic component was hypointense on T1-weighted images and hyperintense on T2-weighted images \[[@B13],[@B18]-[@B20],[@B23],[@B29],[@B33]\]. However, in most cases a diagnosis of a mucinous cystadenoma \[[@B4],[@B15],[@B18]-[@B21],[@B26],[@B27],[@B30],[@B31]\], cystadenocarcinoma \[[@B4],[@B16],[@B18],[@B20]\], pseudocyst \[[@B4],[@B5],[@B17]\], or a potential malignant tumor \[[@B25],[@B34]\] was suspected. Interestingly, in two cases \[[@B23],[@B29]\], an ECIPAS was diagnosed in one \[[@B23]\] and strongly suspected in the other \[[@B29]\] based on CT and MRI findings. The radiological signs were related to the homogeneous attenuation of the solid component of the cyst and the adjacent spleen on enhanced CT studies and T1-weighted magnetic resonance images, and on the smooth cystic nature of the inner wall. Itano *et al*. \[[@B23]\] stated that a relatively adequate splenic mass of AS surrounding the EC is essential for a correct preoperative diagnosis. Additional diagnostic modalities such as endoscopic ultrasonography (EUS), EUS-guided fine needle aspiration of the cystic component, fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) \[[@B31]\], and EUS- elastography \[[@B33]\] may be used as complementary tools in the diagnosis of an ECIPAS. Recently, a promising diagnostic method was suggested by Motosugi *et al*. \[[@B40]\], who reported on five subjects as having ECIPAS by using superparamagnetic iron oxide enhanced MRI. Four of them were followed up without surgical intervention.

Although the lesion is considered to be benign and surgery was avoidable \[[@B41]\] Elit *et al*. \[[@B42]\] reported a squamous cell carcinoma deriving from an EC located in the normal spleen. Taking into account that the lesions of the normal spleen could affect an AS \[[@B5]\], a possible malignant transformation cannot be excluded if the cyst remains unresected. However, no malignancy of an ECIPAS has yet been reported.

Until now, the treatment of ECIPAS consists of surgical removal, either open \[[@B4]-[@B28],[@B30]-[@B32],[@B36]\], or laparoscopic \[[@B29],[@B33]-[@B35]\], with or without splenic preservation. No death has been reported during operation or in the short-term postoperative period.

Conclusions
===========

An ECIPAS is a very rare entity. So far, there are not accurate criteria for the preoperative diagnosis of an ECIPAS, and a definite diagnosis derives from pathological examination after surgical removal. Advances in imaging techniques and familiarity with the radiological findings and clinical characteristics of ECIPAS may help determine the correct management of this lesion.
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